Citation

Todd Hulgan, M.D., M.P.H., Richard H. Haubrich, M.D., Sharon A. Riddler, M.D., M.P.H., Pablo Tebas, M.D., Marylyn D. Ritchie, Ph.D., Grace McComsey, M.D., David W. Haas, M.D., Jeffrey A. Canter, M.D., M.P.H. European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS clinical trials group study A5142. AIDS. 2011 Jan 02; 25(1):37-47. PMID: 20871389; PMCID: PMC2995830.

Citation

Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infection. AIDS. 2011 Nov 28; 25(18):2269-2278. PMID: 21941167.

Citation

Kit Simpson, M.P.H., Ph.D., Rukmini Rajagopalan, M.B.A., R.N., D.Ph., Birgitta Dietz, Kevin W. Garren, Ph.D., Sharon A. Riddler, M.D., M.P.H., Richard H. Haubrich, M.D. Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data. Cost Effectiveness and Resource Allocation. 2011 May 08; 9(1):5. PMID: 21548986; PMCID: PMC3117802.

Citation

Jessica H. Brehm, B.S., Christina M. Lalama, M.S., Michael Hughes, Ph.D., Richard H. Haubrich, M.D., Sharon A. Riddler, M.D., M.P.H., Nicolas Sluis-Cremer, Ph.D., John W. Mellors, M.D. Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the C-terminus of HIV-1 reverse transcriptase. Journal of Acquired Immune Deficiency Syndromes. 2011 Apr 01; 56(4):344-8. PMID: 21350368; PMCID: PMC3086845.

Citation

Heather Ribaudo, Ph.D., Constance A. Benson, M.D., Yu (Evelyn) Zheng, M.S., Susan L. Koletar, M.D., Ann C. Collier, M.D., Judith J. Lok, Ph.D., Marlene Smurzynski, Ph.D., M.S.P.H., Ronald J. Bosch, Ph.D., Barbara Bastow, R.N., B.S.N., Jeffrey T. Schouten, M.D.,J.D. No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001/ALLRT. Clinical Infectious Diseases. 2011 Apr 01; 52(7):929-40. PMID: 21427402; PMCID: PMC3062545.

Citation

Early infant HIV-1 envelopes exhibit more rapid entry kinetics than non-transmitted maternal variants. 2011 Aug 15; PMID: 21843318; PMCID: PMC3189118.

Citation

Association of HIV diversity and survival in HIV-infected Ugandan infants. PLoS One. 2011 Apr 14; 6(4). PMID: 21533179; PMCID: PMC3077388.

Citation

Nelfinavir and Lamivudine Pharmacokinetics During the First Two Weeks of Life. Pediaric Infectious Disease Journal. 2011 Sep 01; 30(9):769-72. PMID: 21666540; PMCID: PMC3158246.

Citation

Rapid intrapartum or postpartum HIV testing at a midwife obstetric unit and a district hospital in South Africa. International Journal of Gynecology & Obstetrics. 2011 Apr 01; 113(1):44-9. PMID: 21251654; PMCID: PMC3087603.

Citation

Mark Mirochnick, Brookie M Best, Alice M Stek, Edmund V Capparelli, Chengcheng Hu, Sandra K Burchett, Steven S Rossi, Elizabeth Hawkins, Michael Basar, Elizabeth Smith, Jennifer S Read, IMPAACT 1026s Study Team. Atazanavir pharmacokinetics with and without tenofovir during pregnancy. Journal of Acquired Immune Deficiency Syndromes. 2011 Apr 15; 56(5):412-419. PMID: 21283017; PMCID: PMC3125419.